BioLife Solutions, Inc. provided earnings guidance for the year 2023. Total revenue for 2023 is expected to range from $144 million to $158 million, reflecting a year-over-year decrease of 11% to 2%. Excluding COVID-19-related revenue, this range reflects a year-over-year decrease of 3% to an increase of 6%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.51 USD | +2.43% |
|
+6.22% | +32.37% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.37% | 991M | |
-4.33% | 183B | |
-1.63% | 104B | |
-3.25% | 68.18B | |
+16.54% | 47.14B | |
-10.90% | 43.97B | |
+5.99% | 40.95B | |
+19.87% | 31.05B | |
-6.00% | 24.11B | |
+12.64% | 24.05B |
- Stock Market
- Equities
- BLFS Stock
- News BioLife Solutions, Inc.
- Biolife Solutions, Inc. Provides Earnings Guidance for the Year 2023